| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |